Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir in Acute Apical Abscess
NCT05266040Phase 2Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Oct 2023
- Primary completion
- Dec 2025
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of valaciclovir in Acute apical abscess, sponsored by University of California, San Francisco. Started Oct 2023; status: recruiting.
02
Drugs
valaciclovir
03
Conditions
Acute apical abscess
Beyond the preview
Go deeper on NCT05266040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266040.